What researchers are learning as they sequence, map, and decode species’ genomes
Advertisement
The Scientist
Most Recent
Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.
A large genome-wide study has identified four single-nucleotide polymorphisms shared between five major psychiatric disorders.
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
Another company has launched a non-invasive DNA screen for genetic disorders in unborn babies, adding to the competition in an emerging market.
A chance encounter with a crab apple tree leads to the discovery of a new bacterial species and clues to the evolution of insect endosymbionts.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
Previously enigmatic circular RNAs have been found to influence gene expression by binding to and blocking another class of regulatory RNA, the microRNAs.
The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
